Recent progress and new trends in the treatment of hepatitis B
- 24 May 2002
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 67 (3) , 458-462
- https://doi.org/10.1002/jmv.10097
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachPublished by Elsevier ,2001
- Lamivudine Treatment Can Overcome Cytotoxic T–Cell Hyporesponsiveness in Chronic Hepatitis B: New Perspectives for Immune TherapyHepatology, 2001
- Use of Interferon for Prevention of Hepatocellular Carcinoma in Cirrhotic Patients with Hepatitis B or Hepatitis C Virus InfectionAnnals of Internal Medicine, 1999
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- The long-term course of chronic hepatitis BHepatology, 1999
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Journal of Clinical Investigation, 1998
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992
- A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking HbeagHepatology, 1992
- Hepatitis B virus.The major etiology of hepatocellular carcinomaCancer, 1988